Literature DB >> 11280626

A cost-effectiveness analysis of stays in intensive care units.

M Sznajder1, P Aegerter, R Launois, Y Merliere, B Guidet.   

Abstract

OBJECTIVE: To evaluate patient outcome and the efficiency of stays in intensive care units (ICUs).
DESIGN: Prospective study.
SETTING: Seven ICUs of teaching hospitals in the Paris area. PATIENTS: Two hundred eleven stays including one in three consecutive patients admitted from September to November 1996.
MEASUREMENTS AND MAIN RESULTS: For each patient, the following information was collected during the ICU stay: diagnosis, severity scores, organ failures, workload, cost and mortality. A cost-effectiveness ratio was computed for 176 stays with at least one organ failure, at hospital discharge and 6 months later. Quality of life was measured with EuroQol questionnaires 6 months after discharge in 64 patients representing 62 % of the patients contacted. The mean total ICU cost per stay was US$ 14,130 (+/- 6,550) (higher for non-survivors--US$ 19,060, median 10,590--than for survivors US$ 12,370, median 5,780). The incremental cost-effectiveness ratio was US$ 1,150 per life-year saved and the incremental cost-utility ratio was US$ 4,100 per quality-adjusted life-year (QALY) saved, without discounting. These results compare favourably with other health-care options. However substantial variations were observed according to age, severity, diagnosis, number of organ failures and discount rate. Intoxication had the lowest ratio (US$ 620/QALY) and acute renal insufficiency the highest (US$ 30,625/QALY).
CONCLUSIONS: This work provides medical and economic information on ICU stays in teaching hospitals and enables comparisons with other health-care options.

Entities:  

Mesh:

Year:  2001        PMID: 11280626     DOI: 10.1007/s001340000760

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

Review 1.  The ethics and reality of rationing in medicine.

Authors:  Leslie P Scheunemann; Douglas B White
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  Should cost considerations be included in medical decisions? Yes.

Authors:  B Guidet; R Beale
Journal:  Intensive Care Med       Date:  2015-07-28       Impact factor: 17.440

Review 3.  Quality of life in adult survivors of critical illness: a systematic review of the literature.

Authors:  David W Dowdy; Mark P Eid; Artyom Sedrakyan; Pedro A Mendez-Tellez; Peter J Pronovost; Margaret S Herridge; Dale M Needham
Journal:  Intensive Care Med       Date:  2005-04-01       Impact factor: 17.440

4.  Determining the economic cost of ICU treatment: a prospective "micro-costing" study.

Authors:  Anne Marie McLaughlin; Judy Hardt; James B Canavan; Maria B Donnelly
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

Review 5.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

6.  Survival and quality of life of patients requiring acute renal replacement therapy.

Authors:  Annika Ahlström; Minna Tallgren; Seija Peltonen; Pirjo Räsänen; Ville Pettilä
Journal:  Intensive Care Med       Date:  2005-07-28       Impact factor: 17.440

Review 7.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure.

Authors:  Rita Linko; Raili Suojaranta-Ylinen; Sari Karlsson; Esko Ruokonen; Tero Varpula; Ville Pettilä
Journal:  Crit Care       Date:  2010-04-12       Impact factor: 9.097

9.  Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial.

Authors:  Brent C Opmeer; Kimberly R Boer; Oddeke van Ruler; Johannes B Reitsma; Hein G Gooszen; Peter W de Graaf; Bas Lamme; Michael F Gerhards; E Philip Steller; Cecilia M Mahler; Huug Obertop; Dirk J Gouma; Patrick Mm Bossuyt; Corianne Ajm de Borgie; Marja A Boermeester
Journal:  Crit Care       Date:  2010-05-27       Impact factor: 9.097

10.  A continuous quality-improvement program reduces nosocomial infection rates in the ICU.

Authors:  Benoit Misset; Jean-François Timsit; Marie-Françoise Dumay; Maité Garrouste; Annie Chalfine; Isabelle Flouriot; Fred Goldstein; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.